<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on Buehler from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated Buehler news from BioPortfolio.com</description>
	<pubDate>Wed, 10 Feb 2010 10:00:38 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=Buehler" rel="self" type="application/rss+xml" />

	
<item><title>Alcon to purchase rights for two eye care products from Sirion Therapeutics</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3933286&amp;HITNO=0&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3933286&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2481610098%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3933286&amp;HITNO=0&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3933286&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2481610098%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PharmaBiz:</description></item>
<item><title>Alcon plans to purchase U.S. rights to two ophthalmic agents from Sirion</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3932332&amp;HITNO=1&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3932332&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2481042025%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3932332&amp;HITNO=1&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3932332&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2481042025%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>OSN Super Site:</description></item>
<item><title>Alcon Buys Ophthalmic Pharmaceutical Assets from Sirion</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3931895&amp;HITNO=2&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3931895&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2480749717%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3931895&amp;HITNO=2&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3931895&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2480749717%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>Alcon To Purchase Ophthalmic Pharmaceutical Assets From Sirion</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3930983&amp;HITNO=3&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3930983&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2480318556%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3930983&amp;HITNO=3&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3930983&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2480318556%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Medical News Today:</description></item>
<item><title>Alcon to Purchase Ophthalmic Pharmaceutical Assets from Sirion</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3929232&amp;HITNO=4&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3929232&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479514511%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3929232&amp;HITNO=4&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3929232&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2479514511%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>Alcon to acquire U.S. rights to Sirion Therapeutics' Durezol and Zirgan</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3926357&amp;HITNO=5&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3926357&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2478223034%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3926357&amp;HITNO=5&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3926357&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2478223034%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News-Medical.Net:</description></item>
<item><title>Alcon to Purchase Ophthalmic Pharmaceutical Assets from Sirion</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3926246&amp;HITNO=6&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3926246&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2478163587%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3926246&amp;HITNO=6&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3926246&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2478163587%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>SmartBrief:</description></item>
<item><title>Alcon to Purchase Ophthalmic Pharmaceutical Assets from Sirion</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3925420&amp;HITNO=7&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3925420&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2477652330%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3925420&amp;HITNO=7&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3925420&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2477652330%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Houston Chronicle:</description></item>
<item><title>Alcon to Purchase Ophthalmic Pharmaceutical Assets from Sirion</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3925400&amp;HITNO=8&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3925400&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2477623595%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3925400&amp;HITNO=8&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3925400&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2477623595%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FOXBusiness.com:</description></item>
<item><title>Alcon to Purchase Ophthalmic Pharmaceutical Assets from Sirion</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3925399&amp;HITNO=9&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3925399&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2477623405%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3925399&amp;HITNO=9&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3925399&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2477623405%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FOXBusiness.com:</description></item>
<item><title>Alcon to Purchase Ophthalmic Pharmaceutical Assets from Sirion</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3925398&amp;HITNO=10&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3925398&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2477622502%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3925398&amp;HITNO=10&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3925398&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2477622502%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>FOXBusiness.com:</description></item>
<item><title>Alcon to Purchase Ophthalmic Pharmaceutical Assets from Sirion - ...</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3925379&amp;HITNO=11&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3925379&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2477602729%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3925379&amp;HITNO=11&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3925379&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2477602729%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Zibb:</description></item>
<item><title>Alcon to Purchase Ophthalmic Pharmaceutical Assets from Sirion</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3925316&amp;HITNO=12&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3925316&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2477560773%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3925316&amp;HITNO=12&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3925316&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2477560773%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>Alcon to Purchase Ophthalmic Pharmaceutical Assets from Sirion</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3925219&amp;HITNO=13&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3925219&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2477515600%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3925219&amp;HITNO=13&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3925219&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2477515600%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Forbes.com:</description></item>
<item><title>Alcon to Purchase Ophthalmic Pharmaceutical Assets from Sirion</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3925217&amp;HITNO=14&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3925217&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2477513398%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=3925217&amp;HITNO=14&amp;MSIZE=37&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=Buehler&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=3925217&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2477513398%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Business Wire via Yahoo!:</description></item>
</channel></rss>